Frontiers in Aging Neuroscience (Jan 2024)

Identification and experimental validation of ferroptosis-related gene lactotransferrin in age-related hearing loss

  • Chaojun Zeng,
  • Chaojun Zeng,
  • Chaojun Zeng,
  • Xi Gu,
  • Xi Gu,
  • Xi Gu,
  • Yuqing Chen,
  • Yuqing Chen,
  • Yuqing Chen,
  • Yanchun Lin,
  • Yanchun Lin,
  • Yanchun Lin,
  • Junying Chen,
  • Junying Chen,
  • Zhifeng Chen,
  • Zhifeng Chen,
  • Zhifeng Chen,
  • Chenyu Chen,
  • Chenyu Chen,
  • Chenyu Chen,
  • Guangnan Yao,
  • Guangnan Yao,
  • Guangnan Yao,
  • Chang Lin,
  • Chang Lin,
  • Chang Lin

DOI
https://doi.org/10.3389/fnagi.2024.1309115
Journal volume & issue
Vol. 16

Abstract

Read online

ObjectiveTo reveal the relationship between ARHL and ferroptosis and screen ferroptosis-related genes (FRGs) in ARHL.MethodsBioinformatics were used to analyze the hub genes and molecular mechanism of ferroptosis in the aging cochleae. Senescence β-galactosidase staining, iron content detection, and micro malondialdehyde (MDA) assay kits were used to measure β-galactosidase activity, and expression of Fe2+ and MDA, respectively. Fluorescence microscope was used for immunofluorescence assay of hub genes. Western blot was used to verify the expression of hub genes in HEI-OC1 cells, cochlear explants, and cochleae of C57BL/6J mice. Data were expressed as mean ± SD of at least three independent experiments.ResultsThe analysis of bioinformatics confirmed that lactotransferrin (LTF) is the hub gene and CEBPA-miR-130b-LTF network is the molecular mechanism for cochlear ferroptosis. Compared with the control group, the experiments proved that the indicators of ferroptosis, including Fe2+, MDA, and LTF were differentially expressed in aging HEI-OC1 cells, aging cochlear explants, and aging cochleae.ConclusionThese results demonstrate that ferroptosis plays an important role in ARHL, and LTF is a potential therapeutic target for ARHL via regulating cochlear ferroptosis.

Keywords